Compounds > etoposide phosphate

etoposide phosphate and Leukocytopenia

etoposide phosphate has been researched along with Leukocytopenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbhaiya, RH; Garrow, C; Greco, A; Hainsworth, JD; Igwenezue, KB; Kaul, S; Miller, AA; Schacter, LP; Srinivas, NR; Thompson, DS1
Barbhaiya, RH; Fields, SZ; Himpler, BS; Igwemezie, LN; Kaul, S; Litam, PP; McAleer, C; Schacter, LP; Schilder, RJ; Wright, J1

Trials

2 trial(s) available for etoposide phosphate and Leukocytopenia

ArticleYear
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days.
    Clinical pharmacology and therapeutics, 1995, Volume: 57, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cohort Studies; Dose-Response Relationship, Drug; Etoposide; Female; Half-Life; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds

1995
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Half-Life; Hemoglobins; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds; Thrombocytopenia

1995